These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5. Ai C; Ma G; Deng Y; Zheng Q; Gen Y; Li W; Li Y; Zu L; Zhou Q Thorac Cancer; 2020 Mar; 11(3):640-650. PubMed ID: 32022430 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of h-prune in breast cancer is correlated with advanced disease status. Zollo M; Andrè A; Cossu A; Sini MC; D'Angelo A; Marino N; Budroni M; Tanda F; Arrigoni G; Palmieri G Clin Cancer Res; 2005 Jan; 11(1):199-205. PubMed ID: 15671547 [TBL] [Abstract][Full Text] [Related]
25. c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer. Fiore LS; Ganguly SS; Sledziona J; Cibull ML; Wang C; Richards DL; Neltner JM; Beach C; McCorkle JR; Kaetzel DM; Plattner R Oncogene; 2014 Sep; 33(36):4508-4520. PubMed ID: 24096484 [TBL] [Abstract][Full Text] [Related]
26. NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma. Tan CY; Chang CL Lab Invest; 2018 Feb; 98(2):219-227. PubMed ID: 28991262 [TBL] [Abstract][Full Text] [Related]
27. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients. Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493 [TBL] [Abstract][Full Text] [Related]
28. Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV. Valentijn LJ; Koster J; Versteeg R Genomics; 2006 Apr; 87(4):483-9. PubMed ID: 16442775 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes. Valentijn LJ; Koppen A; van Asperen R; Root HA; Haneveld F; Versteeg R Cancer Res; 2005 Apr; 65(8):3136-45. PubMed ID: 15833843 [TBL] [Abstract][Full Text] [Related]
30. Human metastasis regulator protein H-prune is a short-chain exopolyphosphatase. Tammenkoski M; Koivula K; Cusanelli E; Zollo M; Steegborn C; Baykov AA; Lahti R Biochemistry; 2008 Sep; 47(36):9707-13. PubMed ID: 18700747 [TBL] [Abstract][Full Text] [Related]
31. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1]. Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527 [TBL] [Abstract][Full Text] [Related]
32. Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1. Murakami M; Meneses PI; Knight JS; Lan K; Kaul R; Verma SC; Robertson ES Int J Cancer; 2008 Aug; 123(3):500-10. PubMed ID: 18470881 [TBL] [Abstract][Full Text] [Related]
33. The multiple regulation of metastasis suppressor NM23-H1 in cancer. Yu L; Wang X; Zhang W; Khan E; Lin C; Guo C Life Sci; 2021 Mar; 268():118995. PubMed ID: 33421524 [TBL] [Abstract][Full Text] [Related]
34. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. Hailat N; Keim DR; Melhem RF; Zhu XX; Eckerskorn C; Brodeur GM; Reynolds CP; Seeger RC; Lottspeich F; Strahler JR J Clin Invest; 1991 Jul; 88(1):341-5. PubMed ID: 2056128 [TBL] [Abstract][Full Text] [Related]
35. A competitive cell-permeable peptide impairs Nme-1 (NDPK-A) and Prune-1 interaction: therapeutic applications in cancer. Ferrucci V; Pennino FP; Siciliano R; Asadzadeh F; Zollo M Lab Invest; 2018 May; 98(5):571-581. PubMed ID: 29449633 [TBL] [Abstract][Full Text] [Related]
36. The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration. Murakami M; Meneses PI; Lan K; Robertson ES Cancer Biol Ther; 2008 May; 7(5):677-88. PubMed ID: 18728402 [TBL] [Abstract][Full Text] [Related]
37. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Leone A; Seeger RC; Hong CM; Hu YY; Arboleda MJ; Brodeur GM; Stram D; Slamon DJ; Steeg PS Oncogene; 1993 Apr; 8(4):855-65. PubMed ID: 8384356 [TBL] [Abstract][Full Text] [Related]
38. Nm23-H1 regulates contact inhibition of locomotion, which is affected by ephrin-B1. Tanaka M; Kuriyama S; Aiba N J Cell Sci; 2012 Sep; 125(Pt 18):4343-53. PubMed ID: 22718351 [TBL] [Abstract][Full Text] [Related]
39. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434 [TBL] [Abstract][Full Text] [Related]
40. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. Negroni A; Venturelli D; Tanno B; Amendola R; Ransac S; Cesi V; Calabretta B; Raschellà G Cell Death Differ; 2000 Sep; 7(9):843-50. PubMed ID: 11042679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]